Mirae Asset 600 trillion · KB 200 trillion surpassed, Hanmi Pharmaceutical and Thailand policy changes
Mirae Asset Global Investments’ assets under management exceeded 600 trillion won, while KB Asset Management surpassed 200 trillion won. Hanmi Pharmaceutical is pursuing exports to Southeast Asia of combination drugs with Organon, including 3 types, and Thailand announced plans to introduce a crypto ETF.
Get free 한미약품 email updates.
Bullstory sends one daily email when new analysis or important company news is available.
The amount of assets managed by domestic asset managers is growing rapidly. Mirae Asset Global Investments announced that its assets under management had surpassed 600 trillion won. The company said balanced growth in overseas ETFs and domestic pension funds was behind the increase.
Mirae Asset Global Investments said it had introduced investment strategies using AI. The company highlighted AI-based portfolios and the expansion of global ETFs. It said its goal was to secure competitiveness in global markets.
KB Asset Management said its assets under management had exceeded 200 trillion won. The company explained that pensions and ETFs were growth drivers. KB launched a new ETF focused on investments in Hyundai Motor and robotics companies.
combination drug 3types to Southeast Asia. Hanmi Pharmaceutical announced that it is pursuing plans to export them in cooperation with Organon. The export plans and scope of cooperation are subject to the terms agreed by the two companies.
There are also changes in regulatory trends in Asia. Thailand announced that it would introduce a crypto ETF. It also set out its goal of establishing itself as a digital-asset hub.
Today’s announcements can be summed up as business expansion by an asset manager, efforts by a pharmaceutical company to export overseas, and changes in crypto-asset policies in some countries. The companies announced their growth strategies and product and policy changes through official statements.